GCC: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in GCC

The GCC prophylactic medicaments containing insulin market rose remarkably to $X in 2022, picking up by X% against the previous year. The total consumption indicated a prominent expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by X% against 2020 indices. As a result, consumption attained the peak level of $X. From 2016 to 2022, the growth of the market remained at a lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in GCC

In value terms, prophylactic medicaments containing insulin production expanded remarkably to $X in 2022 estimated in export price. Over the period under review, production, however, showed a resilient increase. The most prominent rate of growth was recorded in 2016 when the production volume increased by X% against the previous year. Over the period under review, production reached the peak level at $X in 2017; however, from 2018 to 2022, production remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in GCC

In 2022, exports of medicaments containing insulin but not antibiotics in measured doses in GCC expanded rapidly to X tons, with an increase of X% compared with the year before. Over the period under review, exports continue to indicate a significant expansion. The most prominent rate of growth was recorded in 2018 when exports increased by X%. Over the period under review, the exports attained the maximum in 2022 and are expected to retain growth in the immediate term.

In value terms, prophylactic medicaments containing insulin exports soared to $X in 2022. Overall, exports saw significant growth. The growth pace was the most rapid in 2017 with an increase of X%. The level of export peaked in 2022 and is expected to retain growth in the near future.

Exports by Country

The United Arab Emirates (X tons) represented roughly X% of total exports in 2022.

The United Arab Emirates was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics in measured doses exports, with a CAGR of X% from 2012 to 2022. The shares of the largest exporters remained relatively stable throughout the analyzed period.

In value terms, the United Arab Emirates ($X) also remains the largest prophylactic medicaments containing insulin supplier in GCC.

In the United Arab Emirates, prophylactic medicaments containing insulin exports increased at an average annual rate of X% over the period from 2012-2022.

Export Prices by Country

In 2022, the export price in GCC amounted to $X per ton, picking up by X% against the previous year. Over the period under review, the export price showed slight growth. The growth pace was the most rapid in 2016 an increase of X% against the previous year. Over the period under review, the export prices reached the peak figure at $X per ton in 2017; however, from 2018 to 2022, the export prices failed to regain momentum.

As there is only one major export destination, the average price level is determined by prices for the United Arab Emirates.

From 2012 to 2022, the rate of growth in terms of prices for the United Arab Emirates amounted to X% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in GCC

Prophylactic medicaments containing insulin imports rose rapidly to X tons in 2022, surging by X% compared with the previous year. Overall, imports posted a strong expansion. The pace of growth was the most pronounced in 2013 with an increase of X%. The volume of import peaked at X tons in 2020; however, from 2021 to 2022, imports stood at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin imports expanded notably to $X in 2022. Over the period under review, imports continue to indicate a prominent increase. The pace of growth appeared the most rapid in 2013 with an increase of X%. The level of import peaked at $X in 2020; however, from 2021 to 2022, imports remained at a lower figure.

Imports by Country

In 2022, Saudi Arabia (X tons) represented the key importer of medicaments containing insulin but not antibiotics in measured doses, making up X% of total imports. The United Arab Emirates (X tons) took the second position in the ranking, distantly followed by Kuwait (X tons) and Oman (X tons). All these countries together held near X% share of total imports. Qatar (X tons) followed a long way behind the leaders.

Saudi Arabia was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics in measured doses imports, with a CAGR of X% from 2012 to 2022. At the same time, the United Arab Emirates (X%), Oman (X%) and Qatar (X%) displayed positive paces of growth. By contrast, Kuwait (X%) illustrated a downward trend over the same period. While the share of Saudi Arabia (X p.p.) and Kuwait (X p.p.) increased significantly in terms of the total imports from 2012-2022, the share of the United Arab Emirates (X p.p.), Qatar (X p.p.) and Oman (X p.p.) displayed negative dynamics.

In value terms, Saudi Arabia ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in measured doses in GCC, comprising X% of total imports. The second position in the ranking was taken by the United Arab Emirates ($X), with a X% share of total imports. It was followed by Kuwait, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value in Saudi Arabia amounted to X%. In the other countries, the average annual rates were as follows: the United Arab Emirates (X% per year) and Kuwait (X% per year).

Import Prices by Country

In 2022, the import price in GCC amounted to $X per ton, increasing by X% against the previous year. In general, the import price, however, continues to indicate a relatively flat trend pattern. The pace of growth was the most pronounced in 2013 when the import price increased by X% against the previous year. Over the period under review, import prices reached the maximum at $X per ton in 2019; however, from 2020 to 2022, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was the United Arab Emirates ($X per ton), while Oman ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Oman (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :